Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The trial enrolled 300 obese subjects (BMI 27-35 kg/m) across multiple centers and randomized them to AOD-9604 (3 mg subcutaneous injection once or twice daily) or placebo for 12 weeks
miljarder r det samlade vrdet p slda bostder (BR och villa) de 12 senaste mnaderna Din webblsare stds ej lngre
Who Might Benefit from Injections
Any off-label, personal, or clinical use is strictly outside the intended scope of supply
Dosage: 300-500 mcg daily via subcutaneous injection
US$ 26.25
US$ 27.00
US$ 21.98
US$ 21.23
US$ 27.04
US$ 22.38
US$ 20.18
US$ 20.76
US$ 26.98
US$ 24.59
US$ 29.55
